Medline Inc. cash flow to debt ratio of 13.88% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.

Medline Inc.'s free cash flow has decreased 7.69% from $1.41B last year to $1.30B, signaling decreasing performance

Medline Inc.'s debt to equity ratio is 1.09, which means that the company's assets are unhealthy financed, signaling financial risk.

Medline Inc.'s debt has increased relative to shareholder equity from 1.02 last year to 1.09 today, signaling weakened financials

Medline Inc. has a net debt to EBITDA ratio of 5.44x, which exceeds the 3.00x threshold, indicating high leverage and potential financial risk

Medline Inc.'s interest coverage ratio of 2.50 indicates that earnings with margin can cover interest payments on company debt

Medline Inc.'s profit margin has decreased (50.94%) in the last year from 4.70% to 2.31%, signaling decreasing performance

Medline Inc.'s short-term assets of $10.68B exceed its short-term liabilities of $2.49B

Medline Inc.'s return on assets of 1.76% is lower than the 5.00% threshold, indicating inefficient asset utilization

Medline Inc.'s return on equity of 5.45%, is lower than 15.00%, indicating bad performance

Medline Inc.'s operating cash flow exceeds its net income, indicating high-quality earnings backed by actual cash generation

Medline Inc. has insufficient public price history to evaluate earnings stability.

Medline Inc. has positive free cash flow, indicating the company generates cash after capital expenditures

Medline Inc. has a free cash flow yield of 4.54%, which is above the 2.00% threshold, indicating strong cash generation relative to market value

Medline Inc.'s yearly earnings has decreased 3.42% since last year from $1.20B to $1.16B, signaling decreasing performance

Medline Inc.'s yearly revenue has increased 11.47% since last year from $25.51B to $28.43B, signaling increasing performance

ROIC 4.04% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.

Medline Inc.'s 3-year revenue CAGR of 9.85% is positive, indicating growing revenue over the past 3 years

Medline Inc. has insufficient public price history to evaluate revenue consistency.

Medline Inc. has insufficient public price history to evaluate ROE consistency.

Medline Inc. has insufficient data to evaluate this check.

Medline Inc. has an earnings yield of 2.38%, which is below the 4.00% threshold, indicating the stock may be expensive relative to its earnings

Medline Inc. is overvalued relative to its fair value price of 0.00 based on EBITDA multiple model

Medline Inc. has an EV/EBITDA ratio of 20.09x, which exceeds the 20.00x threshold, indicating the stock may be overvalued relative to its operating earnings

Medline Inc. has insufficient data to evaluate this check.

Medline Inc. has insufficient diluted EPS history to calculate the PEG ratio.

Medline Inc. has a price-to-book ratio of 1.52x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value

Medline Inc. has a price-to-sales ratio of 0.97x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue